Kistler-Tiffany Companies’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $378K | Sell |
526
-24
| -4% | -$17.2K | 0.06% | 244 |
|
|
2023
Q1 | $452K | Buy |
550
+191
| +53% | +$157K | 0.09% | 178 |
|
|
2022
Q4 | $259K | Buy |
359
+215
| +149% | +$155K | 0.05% | 218 |
|
|
2022
Q3 | $99K | Buy |
144
+34
| +31% | +$23.4K | 0.02% | 286 |
|
|
2022
Q2 | $65K | Hold |
110
| – | – | 0.01% | 349 |
|
|
2022
Q1 | $77K | Hold |
110
| – | – | 0.01% | 338 |
|
|
2021
Q4 | $69K | Hold |
110
| – | – | 0.01% | 339 |
|
|
2021
Q3 | $67K | Buy |
110
+18
| +20% | +$11K | 0.02% | 335 |
|
|
2021
Q2 | $51K | Buy |
92
+5
| +6% | +$2.77K | 0.01% | 367 |
|
|
2021
Q1 | $41K | Hold |
87
| – | – | 0.01% | 357 |
|
|
2020
Q4 | $42K | Buy |
87
+37
| +74% | +$17.9K | 0.01% | 320 |
|
|
2020
Q3 | $28K | Sell |
50
-9
| -15% | -$5.04K | 0.01% | 350 |
|
|
2020
Q2 | $37K | Buy |
59
+20
| +51% | +$12.5K | 0.01% | 285 |
|
|
2020
Q1 | $15K | Hold |
39
| – | – | 0.01% | 399 |
|
|
2019
Q4 | $15K | Hold |
39
| – | – | 0.01% | 407 |
|
|
2019
Q3 | $11K | Hold |
39
| – | – | ﹤0.01% | 439 |
|
|
2019
Q2 | $12K | Hold |
39
| – | – | ﹤0.01% | 423 |
|
|
2019
Q1 | $16K | Hold |
39
| – | – | 0.01% | 375 |
|
|
2018
Q4 | $15K | Hold |
39
| – | – | 0.01% | 350 |
|
|
2018
Q3 | $16K | Buy |
+39
| New | +$16K | 0.01% | 379 |
|
|
2016
Q3 | – | Sell |
-3
| Closed | -$1K | – | 670 |
|
|
2016
Q2 | $1K | Buy |
+3
| New | +$1K | ﹤0.01% | 601 |
|